This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abramson, J. S.
Right arrow Articles by Pickering, L. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abramson, J. S.
Right arrow Articles by Pickering, L. K.
Related Collections
Right arrow Miscellaneous

PEDIATRICS Vol. 108 No. 6 December 2001, pp. 1392

Prevention of Hepatitis B in Adolescents

To the Editor—

For prevention of hepatitis B in adolescents using Recombivax (Merck and Co Inc, West Point, PA), the Food and Drug Administration has approved the use of a 2-dose 10-µg regimen as an alternative to the 3-dose 5-µg regimen in persons 11 to 15 years of age. A recent commentary by Dr Gregory Poland called "Adolescent Hepatitis B Immunization: Making It Simpler"1 stated a . . . [Full Text of this Article]